Related references
Note: Only part of the references are listed.Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease
John E. Donahue et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
Gilbert Gallardo et al.
NATURE NEUROSCIENCE (2008)
Cerebral clearance of human amyloid-β peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes
Shingo Ito et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Clearance of amyloid-β by circulating lipoprotein receptors
Abhay Sagare et al.
NATURE MEDICINE (2007)
Occurrence and co-localization of amyloid β-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice
Dietmar Rudolf Thal et al.
NEUROBIOLOGY OF AGING (2007)
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
B. D. Zipser et al.
NEUROBIOLOGY OF AGING (2007)
Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats
Karsten Schoeller et al.
BRAIN RESEARCH (2007)
Aβ peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons
Peter M. Clifford et al.
BRAIN RESEARCH (2007)
APOE, vascular pathology, and the AD brain
AG Yip et al.
NEUROLOGY (2005)
The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology
DR Thal et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
The key role of apolipoprotein E in atherosclerosis
K Greenow et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Neurovascular mechanisms of Alzheimer's neurodegeneration
BV Zlokovic
TRENDS IN NEUROSCIENCES (2005)
Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice
WJ Brecht et al.
JOURNAL OF NEUROSCIENCE (2004)
A synthetic peptide blocking the apolipoprotein E/β-amyloid binding mitigates β-amyloid toxicity and fibril formation in vitro and reduces β-amyloid plaques in transgenic mice
M Sadowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
M Koistinaho et al.
NATURE MEDICINE (2004)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A
YJ Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
T Wyss-Coray et al.
NATURE MEDICINE (2003)
Vascular pathology in Alzheimer disease: Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline
DR Thal et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing
CU Pietrzik et al.
EMBO JOURNAL (2002)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
YD Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Impairment of the blood-nerve and blood-brain barriers in apolipoprotein E knockout mice
SM Fullerton et al.
EXPERIMENTAL NEUROLOGY (2001)
Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated αβ deposits in the human entorhinal cortex
DR Thal et al.
ACTA NEUROPATHOLOGICA (2000)
Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase
M Ishigami et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma:: Suppression leads to biochemical and pathological deposition
N Iwata et al.
NATURE MEDICINE (2000)
Share Paper
